Chris Peetz

Chris Peetz serves as the Chief Executive Officer and President of Mirum Pharmaceuticals since November 2018. Additionally, Chris holds the position of Entrepreneur-in-Residence at Frazier Healthcare Partners, where involvement includes founding Flashlight Therapeutics, a company focused on developing therapeutics for unmet medical needs. Previous roles include Chief Executive Officer at Flashlight Therapeutics, Chief Financial Officer at Tobira Therapeutics, Vice President of Finance & Corporate Development at Jennerex Biotherapeutics, and various senior positions at Onyx Pharmaceuticals. Chris's career also includes experience in finance and corporate development at Abgenix and a foundational role as an analyst at ABN AMRO/LaSalle. Chris holds an MBA from the Stanford University Graduate School of Business and has pursued studies at Washington University in St. Louis and ESCP Business School.